Image-Guided Radiation Therapy Market worth $2.4 billion | MarketsandMarkets

CHICAGO, Sept. 12, 2023 /PRNewswire/ -- In the near future, the Image-Guided Radiation Therapy (IGRT) industry is poised for remarkable growth and transformation, driven by cutting-edge technological advancements and a growing emphasis on personalized cancer treatment. IGRT, with its precise targeting of tumors using real-time imaging, will play a pivotal role in minimizing radiation exposure to healthy tissues, thereby reducing side effects and improving patient outcomes. With the integration of artificial intelligence and machine learning algorithms, IGRT systems will become even more sophisticated, enabling oncologists to tailor radiation therapy plans to individual patient needs with unprecedented accuracy. Moreover, the accessibility and affordability of IGRT are expected to increase, ensuring that more patients worldwide can benefit from this revolutionary approach to cancer treatment, ultimately leading to enhanced survival rates and improved quality of life for those battling cancer.

Image-Guided Radiation Therapy Market in terms of revenue was estimated to be worth $1.9 billion in 2023 and is poised to reach $2.4 billion by 2028, growing at a CAGR of 5.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. The expansion of the image-guided radiation therapy market is propelled by several synergistic factors, including robust healthcare infrastructure, escalating cancer prevalence, conducive reimbursement policies, technological innovations, active research initiatives, well-defined regulatory frameworks, growing minimally invasive procedure adoption, and the presence of key market players in developing regions. This amalgamation of drivers has engendered substantial market growth. Continued technological advancements, heightened emphasis on non-invasive cancer interventions, and a supportive healthcare ecosystem are anticipated to sustain this upward trajectory. Nevertheless, market expansion faces constraints posed by competitive alternatives, including automated radiation therapy systems, intensity modulation radiation therapy (IMRT), and other radiotherapeutic approaches.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723

Browse in-depth TOC on "Image-Guided Radiation Therapy Market"

120 - Tables
40 - Figures
200 - Pages

Image-Guided Radiation Therapy Market Scope:

PET/ MRI-guided radiation therapy segment to register a significant growth rate over the forecast period of 2022-2028.

Based on the product, the image-guided radiation therapy market is segmented into LINAC (linear accelerator), 4D gating/ 4D RT, PET/ MRI-guided radiation therapy, CT scanning, and portal imaging. The capability of PET/MRI to furnish functional insights directs the administration of radiation doses, effectively mitigating healthy tissue exposure and subsequently alleviating the occurrence of adverse effects. This contribution significantly bolsters the market trajectory of image-guided radiation therapy, enhancing its appeal and positioning within the healthcare landscape.

PET/MRI facilitates the concurrent capture of both structural and molecular data, offering valuable support for treatment strategizing and immediate evaluation throughout radiation therapy. This distinctive feature reinforces the market advancement of image-guided radiation therapy, augmenting its utility and attractiveness within the medical domain.

The breast cancer application segment accounted for a significant share of the image-guided radiation therapy market in 2022-2028.

Based on the application, the image-guided radiation therapy market is segmented into breast cancer, prostate cancer, head & neck cancer, lung cancer, gastrointestinal cancer, gynaecological cancer, and other applications. The rising incidence of cancer worldwide is a significant driver for the image-guided radiation therapy market. The precision inherent in image-guided radiation therapy (IGRT) mitigates the necessity for frequent and discomforting repositioning of patients during treatment sessions. This is attributed to an enhanced level of patient comfort, particularly pertinent for individuals undergoing breast cancer treatment. This augmentation distinctly contributes to the advancement and attractiveness of the image-guided radiation therapy market.

IGRT enables precise tumor localization, enabling dynamic adjustments during treatment to ensure accurate radiation delivery to the tumor site. This adeptness minimizes the risk of impacting neighbouring healthy tissues unfavourably. As a result, this capability significantly contributes to the amplification of the market prominence of image-guided radiation therapy, fortifying its appeal and value proposition.

Intensity modulation radiation therapy procedure segment accounted for the largest share of the image-guided radiation therapy market in 2022-2028.

Based on the procedure, the image-guided radiation therapy market is segmented into 3D conformal therapy, stereotactic therapy, proton beam therapy, intensity modulation radiation therapy, and particle therapy. The intensity modulation radiation therapy procedure segment is estimated to hold the 39.2% market share of the image-guided radiation therapy market in 2022. Intensity Modulated Radiation Therapy (IMRT) is instrumental in crafting tailored treatment blueprints through the optimization of radiation administration based on tumor dimensions, contours, and placement. This congruence aligns seamlessly with the personalized treatment ethos central to Image-Guided Radiation Therapy (IGRT). The heightened precision characteristic of IMRT translates to diminished radiation exposure to vital organs and unaffected tissues, thereby attenuating the potential for treatment-induced complications. This correlation distinctly resonates with IGRT's mission to curtail adverse effects, collectively accentuating its market viability and relevance.

Hospitals segment to register for the largest market share of the image-guided radiation therapy market in 2022-2028.

The major end users in the image-guided radiation therapy market are independent radiotherapy centers and hospitals. Hospitals are expected to account for a major market share in 2022. Healthcare institutions grapple with a considerable influx of cancer patients, thereby magnifying the attraction towards image-guided radiation therapy (IGRT). The precision inherent in IGRT's tumor-targeting proficiency and its streamlined treatment delivery harmonize seamlessly with the necessity of proficiently managing the patient caseload. This symbiotic convergence not only optimizes patient-centric care but also elevates the market appeal of image-guided radiation therapy, establishing it as a pivotal therapeutic modality for healthcare establishments addressing the complexities of cancer treatment management.

Overall, Within the sphere of image-guided radiation therapy (IGRT), the hospital's end-user segment strategically capitalizes on its comprehensive healthcare provisions, state-of-the-art infrastructure, synergistic collaborative milieu, and unwavering commitment to patient-centered care to propel adoption. The cumulative impact of these facets distinctly fosters the expansion and heightened prominence of IGRT's presence within the hospital ecosystem, consequently amplifying its market position and traction.

North America to account for a significant market share in the image-guided radiation therapy market in 2022.

In 2022, the North American region is expected to register significant growth in the market during the forecast period. North America comprises the US and Canada. North America has an advanced healthcare infrastructure, which is associated with a higher incidence of cancer. In North America, a highly developed healthcare infrastructure coupled with ready access to state-of-the-art medical technologies creates a conducive environment for the assimilation of progressive treatment modalities, such as image-guided radiation therapy (IGRT). The region's notably comprehensive healthcare reimbursement frameworks further reinforce the adoption of sophisticated treatments, including IGRT, ensuring its accessibility to a broader spectrum of patients. This confluence of factors substantiates the impetus for the expansion and fortification of the image-guided radiation therapy market.

These factors collectively contribute to North America's good market share in the image-guided radiation therapy market, making it a prominent region for the adoption, manufacturing, and research of image-guided radiation therapy.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171554723

Image-Guided Radiation Therapy Market Dynamics:

Drivers:

1. Increase in non-invasive cancer treatments through radiation therapy
2. Increasing government initiatives for cancer management
3. Rising cancer patient population

Restraints:

1. The dearth of skilled radiologist/oncologist
2. Affordability and accessibility of treatment
3. Complexity of imaging technology for treatments

Opportunities:

1. Rising healthcare expenditure across developing countries
2. Expansion of key players in emerging countries

Challenge:

1. Availability of alternative technology

Key Market Players:

As of 2022, prominent players in the image-guided radiation therapy market are Siemens Healthineers AG (Germany), Elekta (Sweden), and Accuray Incorporated (US), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=171554723

Image-Guided Radiation Therapy Market Advantages:

• Precision and Accuracy: IGRT provides real-time, high-resolution imaging during radiation therapy, allowing for precise targeting of tumors. This accuracy minimizes radiation exposure to healthy tissues and critical structures, reducing side effects and improving treatment outcomes.
• Enhanced Safety: By continuously monitoring the patient's position and adjusting the radiation beam accordingly, IGRT significantly reduces the risk of errors and ensures that the radiation is delivered to the intended target, enhancing patient safety.
• Personalized Treatment: IGRT enables oncologists to customize radiation therapy plans based on the specific anatomy and response of each patient, optimizing treatment effectiveness while minimizing damage to healthy tissues.
• Reduced Treatment Time: With improved accuracy and efficiency, IGRT can reduce the overall duration of radiation therapy courses, enhancing patient convenience and comfort.
• Minimized Toxicity: By sparing healthy tissues and organs from unnecessary radiation exposure, IGRT helps mitigate acute and long-term side effects, improving the patient's quality of life during and after treatment.
• Adaptive Radiation Therapy (ART): IGRT facilitates the implementation of ART, which involves modifying treatment plans in real-time based on changes in the tumor's size, shape, or position. This adaptability ensures that the therapy remains effective throughout the course of treatment.
• Improved Outcomes: The precision and effectiveness of IGRT often result in better tumor control and higher survival rates, especially for challenging cases or tumors located near critical structures.
• Patient Comfort: IGRT's non-invasive approach and reduced treatment times enhance patient comfort and compliance, making it a preferred choice for many individuals undergoing radiation therapy.
• Cost-Efficiency: While IGRT technology has upfront costs, its ability to optimize treatment plans, reduce side effects, and improve outcomes can lead to long-term cost savings by minimizing the need for additional treatments or managing complications.
• Wider Accessibility: As technology advances and becomes more widely available, IGRT is becoming accessible to more healthcare facilities and patients, extending its benefits to a broader population.

In conclusion, the Image-Guided Radiation Therapy market offers a host of advantages that are revolutionizing cancer treatment, ultimately leading to improved patient outcomes, enhanced safety, and a higher quality of life for individuals undergoing radiation therapy.

Recent Developments:

• In 2023, Philips extended the company's mobile C-arm portfolio with Zenition 10.
• In 2023, GE HealthCare Advances PET/MR Capabilities with AIR Technologies to enhance diagnostic precision and simplify treatment evaluation while elevating patient comfort.
• In 2023, The launch of Pixxoscan expands GE HealthCare's portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) and Pixxoscan (gadobutrol).

Related Reports:

Positron Emission Tomography Market - Global Forecasts to 2028

Quantum Computing in Healthcare Market - Global Forecasts to 2028

Radiotherapy Market - Global Forecasts to 2027

Radiation Detection Monitoring Safety Market - Global Forecasts to 2027

Patient Positioning Systems Market - Global Forecasts to 2027

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/image-guided-radiation-therapy-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/image-guided-radiation-therapy.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg